Logotipo do repositório
 

Publicação:
Novel transdermal bioadhesive surfactant-based system for release and solubility improvement of antimalarial drugs artemether-lumefantrine

dc.contributor.authorVolpe-Zanutto, Fabiana
dc.contributor.authorFonseca-Santos, Bruno [UNESP]
dc.contributor.authorMcKenna, Peter E.
dc.contributor.authorParedes, Alejandro J
dc.contributor.authorDávila, José Luis
dc.contributor.authorMcCrudden, Maelíosa T. C.
dc.contributor.authorTangerina, Marcelo Marucci Pereira
dc.contributor.authorCeccheto Figueiredo, Mariana
dc.contributor.authorVilegas, Wagner [UNESP]
dc.contributor.authorBrisibe, Andi
dc.contributor.authorAkira D'vila, Marcos
dc.contributor.authorDonnelly, Ryan F.
dc.contributor.authorChorilli, Marlus [UNESP]
dc.contributor.authorFoglio, Mary Ann
dc.contributor.institutionUniversity at Campinas
dc.contributor.institutionQueen's University Belfast
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institution3D Printing Open Lab - Laprint
dc.contributor.institutionInstituto de Biociencias
dc.contributor.institutionUniversidade Estadual de Campinas (UNICAMP)
dc.contributor.institutionUniversity of Calabar
dc.date.accessioned2022-04-29T08:35:30Z
dc.date.available2022-04-29T08:35:30Z
dc.date.issued2021-11-01
dc.description.abstractArtemether (ART) and lumefantrine (LUM) are the gold standard antimalarial drugs used for the treatment of malaria in children and pregnant women. Typically, ART and LUM are delivered orally in the form of a combined tablet, however, the appropriateness of this route of administration for these drugs is questionable due to the poor absorption and therefore bioavailability observed unless administered alongside lipid-rich foods. Transdermal drug delivery in the form of a patch-type system has been identified as a viable alternative to the conventional tablet-based therapy. A novel, surfactant-based ART-LUM formulation (S3AL), developed for transdermal delivery, may eliminate the shortcomings associated with oral delivery; namely poor drug absorption which is caused by the inherently low solubility of ART and LUM. Moreover, by successfully delivering these antimalarials transdermally, first-pass metabolism will be avoided leading to enhanced drug bioavailability in both cases. The S3AL formulation contained ART and LUM at equal concentrations (2.5% w/w of each) as well as Procetyl® AWS (30% w/w), oleic acid (10% w/w), 1-methyl-2-pyrrolidone (10% w/w), and water (45% w/w). The addition of LUM to the formulation changed the system from a striae structure to a dark field structure when visualized by a polarized light microscope. Additionally, this system possessed higher viscosity and superior skin bioadhesion, as evidenced by mechanical characterization, when compared to a similar formulation containing ART alone. S3AL was also proven to be biocompatible to human keratinocyte cells. Finally, in vitro studies demonstrated the propensity of S3AL for successful delivery via the transdermal route, with 2279 295 µg cm-2 of ART and 94 13 µg cm-2 of LUM having permeated across dermatomed porcine skin after 24 h, highlighting its potential as a new candidate for the treatment of malaria.en
dc.description.affiliationGraduate School of Bioscience and Technology of Bioactive Products Biology Institute University at Campinas, Sao Paulo
dc.description.affiliationSchool of Pharmacy Queen's University Belfast
dc.description.affiliationUNESP- University Estadual Paulista Faculdade de Ciencias Farmaceuticas UNESP, Sao Paulo
dc.description.affiliationFaculty of Pharmaceutical Science University at Campinas, Sao Paulo
dc.description.affiliationCentre for Information Technology 'Renato Archer' (CTI) 3D Printing Open Lab - Laprint, Sao Paulo
dc.description.affiliationUniversidade de S o Paulo Departamento de Bot nica Instituto de Biociencias, Sao Paulo
dc.description.affiliationFaculdade de Ciencias Médicas Universidade Estadual de Campinas, Sao Paulo
dc.description.affiliationSchool of Mechanical Engineering University of Campinas, Sao Paulo
dc.description.affiliationUNESP Univ Estadual Paulista Instituto de Biociencias, Sao Vicente
dc.description.affiliationUniversity of Calabar
dc.description.affiliationUnespUNESP- University Estadual Paulista Faculdade de Ciencias Farmaceuticas UNESP, Sao Paulo
dc.description.affiliationUnespUNESP Univ Estadual Paulista Instituto de Biociencias, Sao Vicente
dc.identifierhttp://dx.doi.org/10.1088/1748-605X/ac2885
dc.identifier.citationBiomedical Materials (Bristol), v. 16, n. 6, 2021.
dc.identifier.doi10.1088/1748-605X/ac2885
dc.identifier.issn1748-605X
dc.identifier.issn1748-6041
dc.identifier.scopus2-s2.0-85117235799
dc.identifier.urihttp://hdl.handle.net/11449/229721
dc.language.isoeng
dc.relation.ispartofBiomedical Materials (Bristol)
dc.sourceScopus
dc.subjectartemether
dc.subjectlumefantrine
dc.subjectmalaria
dc.subjectsurfactant-based system
dc.subjecttransdermal
dc.titleNovel transdermal bioadhesive surfactant-based system for release and solubility improvement of antimalarial drugs artemether-lumefantrineen
dc.typeArtigo
dspace.entity.typePublication
unesp.author.orcid0000-0003-0148-1080 0000-0003-0148-1080[1]
unesp.author.orcid0000-0002-0414-8972[4]
unesp.author.orcid0000-0003-0502-5963[5]
unesp.author.orcid0000-0003-1981-9692[11]
unesp.campusUniversidade Estadual Paulista (UNESP), Instituto de Biociências, São Vicentept
unesp.departmentCiências Biológicas - IBCLPpt

Arquivos